D. Hilton

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies.

P. Mclaughlin, D. Feiglin, H. Rakowski, 1982, The American journal of cardiology.

Three-month efficacy and safety of once-daily diltiazem in chronic stable angina pectoris.

M. Alexander, M. Baird, C. Nadeau, 1995, The American journal of cardiology.